Phibro Animal Health Corporation reiterated earnings guidance for the year ending June 30, 2023. For the year, the company expects Net sales of $960 million - $1 billion, Net income of $34 million - $38 million, and Diluted EPS of $0.84 - $0.94.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.74 USD | -1.31% | +1.08% | +53.20% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.20% | 728M | |
-11.93% | 79.26B | |
+14.23% | 8.39B | |
+28.00% | 3.74B | |
-1.39% | 3.27B | |
+21.28% | 1.69B | |
-3.25% | 1.56B | |
-18.63% | 1.29B | |
-1.17% | 1.28B | |
-6.77% | 1.14B |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Reiterates Earnings Guidance for the Year Ending June 30, 2023